Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$316,582,882
+$110,886,319 QoQ
Shares Held
3,883,976
+18.4% QoQ
Ownership
2.75%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#8
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ARWR ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,582,882 | 3,883,976 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $205,696,563 | 3,280,647 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $36,365,650 | 547,758 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $17,344,742 | 502,892 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,050,103 | 762,665 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,001,377 | 314,080 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,313,215 | 176,235 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,704,486 | 242,875 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,745,858 | 259,556 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,271,263 | 254,240 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $70,573,023 | 2,306,308 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $65,644,428 | 2,443,038 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $79,465,455 | 2,228,420 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $55,392,140 | 2,180,793 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $88,599,342 | 2,184,402 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $73,233,179 | 2,215,830 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,506,891 | 2,201,275 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $107,344,061 | 2,334,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $152,863,997 | 2,305,641 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $144,428,244 | 2,313,443 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $207,589,653 | 2,506,516 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $224,851,173 | 3,390,909 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $250,052,709 | 3,258,865 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $141,376,873 | 3,283,253 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $143,917,458 | 3,332,194 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $91,204,926 | 3,170,140 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||